Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BlueOne Card (BCRD) Liabilities and Shareholders Equity (2020 - 2025)

BlueOne Card has reported Liabilities and Shareholders Equity over the past 5 years, most recently at $15.2 million for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity fell 3.16% year-over-year to $15.2 million; the TTM value through Dec 2025 reached $61.4 million, up 233.61%, while the annual FY2025 figure was $15.5 million, 1475.47% up from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $15.2 million at BlueOne Card, down from $15.3 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $15.7 million in Q4 2024 and troughed at $432060.0 in Q3 2022.
  • A 5-year average of $4.5 million and a median of $934465.0 in 2024 define the central range for Liabilities and Shareholders Equity.
  • Biggest five-year swings in Liabilities and Shareholders Equity: crashed 54.62% in 2024 and later surged 1728.37% in 2025.
  • Year by year, Liabilities and Shareholders Equity stood at $486330.0 in 2021, then grew by 8.54% to $527879.0 in 2022, then soared by 121.45% to $1.2 million in 2023, then skyrocketed by 1242.07% to $15.7 million in 2024, then fell by 3.16% to $15.2 million in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for BCRD at $15.2 million in Q4 2025, $15.3 million in Q3 2025, and $15.4 million in Q2 2025.